Literature DB >> 11282762

Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease.

D E O'Donnell1, C D'Arsigny, K A Webb.   

Abstract

We studied interrelationships between exercise endurance, ventilatory demand, operational lung volumes, and dyspnea during acute hyperoxia in ventilatory-limited patients with advanced chronic obstructive pulmonary disease (COPD). Eleven patients with COPD (FEV(1.0) = 31 +/- 3% predicted, mean +/- SEM) and chronic respiratory failure (Pa(O(2)) 52 +/- 2 mm Hg, Pa(CO(2 ))48 +/- 2 mm Hg) breathed room air (RA) or 60% O(2) during two cycle exercise tests at 50% of their maximal exercise capacity, in randomized order. Endurance time (T(lim)), dyspnea intensity (Borg Scale), ventilation (V E), breathing pattern, dynamic inspiratory capacity (IC(dyn)), and gas exchange were compared. Pa(O(2)) at end-exercise was 46 +/- 3 and 245 +/- 10 mm Hg during RA and O(2), respectively. During O(2), T(lim) increased 4.7 +/- 1.4 min (p < 0.001); slopes of Borg, V E, V CO(2), and lactate over time fell (p < 0.05); slopes of Borg-V E, V E-V CO(2), V E-lactate were unchanged. At a standardized time near end-exercise, O(2) reduced dyspnea 2.0 +/- 0.5 Borg units, V CO(2) 0.06 +/- 0.03 L/min, V E 2.8 +/- 1.0 L/min, and breathing frequency 4.4 +/- 1.1 breaths/min (p < 0.05 each). IC(dyn) and inspiratory reserve volume (IRV) increased throughout exercise with O(2) (p < 0.05). Increased IC(dyn) was explained by the combination of increased resting IRV and decreased exercise breathing frequency (r(2) = 0.83, p < 0.0005). In conclusion, improved exercise endurance during hyperoxia was explained, in part, by a combination of reduced ventilatory demand, improved operational lung volumes, and dyspnea alleviation.

Entities:  

Mesh:

Year:  2001        PMID: 11282762     DOI: 10.1164/ajrccm.163.4.2007026

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  43 in total

1.  Chronic obstructive pulmonary disease in China: the potential role of indacaterol.

Authors:  Jinming Gao; Niyati Prasad
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

Review 2.  Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline.

Authors:  Darcy D Marciniuk; Donna Goodridge; Paul Hernandez; Graeme Rocker; Meyer Balter; Pat Bailey; Gord Ford; Jean Bourbeau; Denis E O'Donnell; Francois Maltais; Richard A Mularski; Andrew J Cave; Irvin Mayers; Vicki Kennedy; Thomas K Oliver; Candice Brown
Journal:  Can Respir J       Date:  2011 Mar-Apr       Impact factor: 2.409

Review 3.  COPD: what is the unmet need?

Authors:  P M A Calverley
Journal:  Br J Pharmacol       Date:  2008-09-15       Impact factor: 8.739

4.  Impact of pulmonary system limitations on locomotor muscle fatigue in patients with COPD.

Authors:  Markus Amann; Mark S Regan; Majd Kobitary; Marlowe W Eldridge; Urs Boutellier; David F Pegelow; Jerome A Dempsey
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05-05       Impact factor: 3.619

5.  Effect of therapeutic hyperoxia on maximal oxygen consumption and perioperative risk stratification in chronic obstructive pulmonary disease.

Authors:  Hilary M Womble; Richard M Schwartzstein; Richard P Johnston; David H Roberts
Journal:  Lung       Date:  2012-01-17       Impact factor: 2.584

Review 6.  Oxygen therapy in chronic obstructive pulmonary disease.

Authors:  Victor Kim; Joshua O Benditt; Robert A Wise; Amir Sharafkhaneh
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

7.  Air Current Applied to the Face Improves Exercise Performance in Patients with COPD.

Authors:  Nathaniel Marchetti; Matthew R Lammi; John M Travaline; David Ciccolella; Brian Civic; Gerard J Criner
Journal:  Lung       Date:  2015-08-09       Impact factor: 2.584

8.  Does prior training affect acute O₂ supply responses during exercise in Desaturator COPD patients?

Authors:  Delphine Delample; Meritxell Sabate; Christian Préfaut; Fabienne Durand
Journal:  Open Respir Med J       Date:  2008-03-13

Review 9.  Is there any treatment other than drugs to alleviate dyspnea in COPD patients?

Authors:  Nicolino Ambrosino; Guido Vagheggini
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

Review 10.  Palliative management of refractory dyspnea in COPD.

Authors:  Hope E Uronis; David C Currow; Amy P Abernethy
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.